Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks

Michael Siluk / UCG / Universal Images Group / Getty Images Novo Nordisk shares have lost more than a third of their value this year as the company faces growing competition in the market for weight-loss drugs. Key Takeaways President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and Eli Lilly Friday. Centers for Medicare & Medicaid Services head Dr. Mehmet Oz said price negotiations have not finished yet. Novo Nordisk (NVO) and Eli L ...